Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates.
about
Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacinIncreased fluoroquinolone resistance with time in Escherichia coli from >17,000 patients at a large county hospital as a function of culture site, age, sex, and location.Alternating antibiotic treatments constrain evolutionary paths to multidrug resistanceA practical guide to measuring mutation rates in antibiotic resistance.The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells.Distribution of quinolones, sulfonamides, tetracyclines in aquatic environment and antibiotic resistance in indochina.Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done.Fluoroquinolone-resistant mutants of Burkholderia cepaciaAntibiotic resistance pattern among common bacterial uropathogens with a special reference to ciprofloxacin resistant Escherichia coli.Surveillance of multidrug resistant uropathogenic bacteria in hospitalized patients in Indian.Controlling mutation: intervening in evolution as a therapeutic strategy.Moxifloxacin Improves Treatment Outcomes in Patients with Ofloxacin-Resistant Multidrug-Resistant TuberculosisPrediction of Drug Penetration in Tuberculosis LesionsSide effects of antibiotics on genetic variability.DNA repair in Mycobacterium tuberculosis revisited.Bacterial stress responses as determinants of antimicrobial resistance.Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis.Evolution of Drug Resistance in Bacteria.Population Heterogeneity in Mutation Rate Increases the Frequency of Higher-Order Mutants and Reduces Long-Term Mutational Load.Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives.The Complex Relationship between Virulence and Antibiotic Resistance.Mutational Consequences of Ciprofloxacin in Escherichia coliEffects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus.Relationships among ciprofloxacin, gatifloxacin, levofloxacin, and norfloxacin MICs for fluoroquinolone-resistant Escherichia coli clinical isolatesMycobacterium tuberculosis Beijing genotype resistance to transient rifampin exposure.Concentration-dependent activity of antibiotics in natural environments.gyrA mutations and phenotypic susceptibility levels to ofloxacin and moxifloxacin in clinical isolates of Mycobacterium tuberculosis.Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis.Generation of resistant mutants of Mycobacterium chelonae and Mycobacterium fortuitum after exposure to subinhibitory concentrations of clarithromycin and moxifloxacin.Evolution of drug resistance in Mycobacterium tuberculosis: a review on the molecular determinants of resistance and implications for personalized care.Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials.Phenotypic Switching Can Speed up Microbial Evolution.
P2860
Q28486678-775A3DEE-AC7E-46A3-9FD7-4D83290D3A47Q33314977-23B41C52-4FAA-4DF8-AAEF-4FAAD674174AQ34407557-E877FD62-E143-44FB-AF32-9F08846F4F68Q34746116-F05F1B62-5D6A-4CC2-A388-2F0F01177FAEQ35125060-AF3B7226-82C3-4DBA-BD78-633F48B972E2Q35770105-BD9F490B-B53A-4295-B6CD-09FDD19593F1Q36094210-D569AB20-6C60-4486-8C5C-36A5C70BE2F4Q36482751-128676D6-918F-42DE-BF15-8118F8746F22Q36613199-62EC0AB4-1A4A-4E13-AF2F-A8022ADD6BFCQ36791550-E03EC8B0-3BCB-485B-B28C-2492792EECCCQ36961674-56B91197-AD6F-4AF9-8CDF-E71B479901D5Q37120071-74C63099-C348-49CA-ACC9-4CD4FC9B62F0Q37265786-2536DFB6-E91A-4C56-AF1F-15069778D593Q37406333-FB01FECB-DC34-44F1-B85F-7ABDE4F7C584Q37455209-71C93109-DB15-4A0A-A6BC-BADB19A3F626Q38012391-474D0A37-5691-48BD-A32E-2AE8AA17ADB7Q38144839-E53517F5-960C-43E8-9F80-DB47070085FDQ38837707-94575C03-BE18-4F3A-ABAE-8C01E7C3380AQ39005916-96F0202B-9CBE-47D0-8D83-0729A39F3262Q39038482-E60B5E6D-24E9-4CFB-B56D-EFC272C42A3FQ39096546-B49964B2-B75C-4C04-A8B4-AE4791019BF5Q41194789-8729DAC0-9D34-4F50-ADE6-B320DD5D9224Q41773256-8F2000E8-AD86-4FA8-BDCE-D4CC72FA99D1Q41975822-0E46285B-DA11-48BD-8574-35B0B3F18708Q42968654-0872543D-673B-4A66-BC13-19FEDF11CEF6Q43245583-AF88F7DE-59B8-4FB1-9C23-DEACCAEA3C36Q46168942-AAD44ECB-F554-47A3-8B57-6CE79BC7366CQ46478240-408BA220-261C-4965-8677-52CD716FB85DQ46855573-90947399-A370-4DF0-A7A0-E2F422785B2FQ52707803-BD2394CE-BBDA-4B05-85BB-59434CA4DCC3Q54372713-64EB0339-D148-4CD0-A6E7-F8A66A284927Q55402036-B257C501-4CF6-4FD2-BAE8-2BC48DAE09B2
P2860
Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Effect of subinhibitory concen ...... rium fortuitum mutation rates.
@en
Effect of subinhibitory concen ...... rium fortuitum mutation rates.
@nl
type
label
Effect of subinhibitory concen ...... rium fortuitum mutation rates.
@en
Effect of subinhibitory concen ...... rium fortuitum mutation rates.
@nl
prefLabel
Effect of subinhibitory concen ...... rium fortuitum mutation rates.
@en
Effect of subinhibitory concen ...... rium fortuitum mutation rates.
@nl
P2093
P2860
P356
P1476
Effect of subinhibitory concen ...... rium fortuitum mutation rates.
@en
P2093
Anne L Dickens
Denise M O'Sullivan
Shreya Basu
Stephen H Gillespie
P2860
P304
P356
10.1093/JAC/DKI191
P407
P577
2005-06-14T00:00:00Z